Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001944989 | SCV002180784 | uncertain significance | not provided | 2021-07-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with cysteine at codon 1733 of the MCM3AP protein (p.Gly1733Cys). The glycine residue is highly conserved and there is a large physicochemical difference between glycine and cysteine. This variant is present in population databases (rs564457343, ExAC 0.1%). This variant has not been reported in the literature in individuals with MCM3AP-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003130599 | SCV003810831 | uncertain significance | Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development | 2022-09-12 | criteria provided, single submitter | clinical testing |